Cost-consequence analysis of an intervention for the management of neuropsychiatric symptoms in young-onset dementia:Results from the BEYOND-II study by van Duinen-van den IJssel, Jeannette C. L. et al.
  
 University of Groningen
Cost-consequence analysis of an intervention for the management of neuropsychiatric
symptoms in young-onset dementia
van Duinen-van den IJssel, Jeannette C. L.; Bakker, Christian; Smalbrugge, Martin; Zwijsen,
Sandra A.; Adang, Eddy; Appelhof, Britt; Zuidema, Sytse U.; de Vugt, Marjolein E.; Verhey,
Frans R. J.; Koopmans, Raymond T. C. M.
Published in:
International Journal of Geriatric Psychiatry
DOI:
10.1002/gps.5229
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
van Duinen-van den IJssel, J. C. L., Bakker, C., Smalbrugge, M., Zwijsen, S. A., Adang, E., Appelhof, B., ...
Koopmans, R. T. C. M. (2019). Cost-consequence analysis of an intervention for the management of
neuropsychiatric symptoms in young-onset dementia: Results from the BEYOND-II study. International
Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.5229
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 11-12-2019
Received: 19 February 2019 Accepted: 24 September 2019
DOI: 10.1002/gps.5229R E S E A R CH AR T I C L ECost‐consequence analysis of an intervention for the
management of neuropsychiatric symptoms in young‐onset
dementia: Results from the BEYOND‐II studyJeannette C.L. van Duinen‐van den IJssel1,2 | Christian Bakker1,2,3 | Martin Smalbrugge4 |
Sandra A. Zwijsen4 | Eddy Adang5 | Britt Appelhof1,2,6 | Sytse U. Zuidema7 |
Marjolein E. de Vugt8 | Frans R.J. Verhey8 | Raymond T.C.M. Koopmans1,2,91Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands
2Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands
3Groenhuysen, Center for Geriatric Care, Roosendaal, The Netherlands
4Department of General Practice and Elderly Care Medicine/Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, The Netherlands
5Department for Health Evidence, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands
6Archipel Care Group, Landrijt, Center for Specialized Care, Eindhoven, The Netherlands
7Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
8School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands
9De Waalboog, “Joachim en Anna”, Center for Specialized Geriatric Care, Nijmegen, the NetherlandsCorrespondence
Christian Bakker, MSc, PhD, Primary Care
Department, Radboud University Medical




Archipel Care Group the Netherlands; Dutch
Alzheimer Society; Dutch Young‐onset
Dementia Knowledge Center; Florence Care
Group, the Netherlands; Netherlands Organi-
zation for Health Research and Development
(ZonMW), Grant/Award Number: 733050402- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of
medium, provided the original work is properly cite
© 2019 The Authors. International Journal of Geri
Int J Geriatr Psychiatry. 2019;1–7.Objective: To evaluate the cost‐consequences of an intervention for the manage-
ment of neuropsychiatric symptoms in nursing home residents with young‐onset
dementia.
Methods: A stepped wedge design was used. The intervention consisted of an edu-
cational program and a multidisciplinary care program and was implemented in 13
nursing homes from September 2015 to March 2017. Costs' outcomes included the
time investment of the elderly care physician and health care psychologists regarding
the management of neuropsychiatric symptoms, residents' psychotropic drug use,
nursing staff absenteeism, and costs of the educational program. Composite cost
measure contained the sum of costs of staff absenteeism, costs on psychotropic
drugs, and costs of the educational program. Costs of time investment were investi-
gated by comparing means. Costs of psychotropic drug use were analyzed with mixed
models at resident level and as part of the composite cost measure on unit level. Staff
absenteeism was also analyzed at unit level.
Results: Compared with care as usual, the mean costs of time invested decreased
with €36.79 for the elderly care physician but increased with €46.05 for the health
care psychologist in the intervention condition. Mixed model analysis showed no
effect of the intervention compared with care as usual on the costs of psychotropic
drug use, staff absenteeism, and the composite cost measure. The costs of the edu-
cational program were on average €174.13 per resident.- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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2 VAN DUINEN‐VAN DEN IJSSEL ET AL.Conclusion: The intervention did not result in increased costs compared with care
as usual. Other aspects, such as the lack of a structured working method, should be
taken into account when considering implementation of the intervention.
KEYWORDS
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young‐onset dementiaKey points
• Costs of psychotropic drug use and staff absenteeism did
not differ between the use of the intervention and care
as usual.
• An average cost of time invested on the management of
neuropsychiatric symptoms decreased for the elderly
care physician but increased for the health care
psychologist in the intervention condition.
• The intervention is of interest for nursing homes in need
for a methodological and multidisciplinary approach
towards the management of neuropsychiatric symptoms
in nursing home residents with young‐onset dementia.1 | INTRODUCTION
The prevalence of dementia worldwide is around 50 million and is
expected to rise to 75 million people1 in 2030. According to the
WHO, the costs of dementia care worldwide were 818 billion US
dollars in 2015 and are expected to rise to 2 trillion US dollars in1
2030. In the Netherlands, currently 270 000 people have dementia
of which 70 000 people live in long‐term care facilities, and this is
expected to increase.2 The costs for care for people with dementia
living in long‐term care facilities in the Netherlands were 5.19 billion
US dollars2 in 2015, and this will likely increase in the upcoming
years. Of all the people with dementia, about 6% to 9% develop
the first symptoms before the age of 65, which is the so‐called
young‐onset dementia (YOD).3 In the Netherlands, approximately
12 000 people have YOD.2
Research shows that one of the important cost‐drivers of nursing
home care is related to the presence of neuropsychiatric symptoms
(NPS).4 Indeed, NPS are highly prevalent in nursing home residents
with late‐onset dementia5 resulting in negative health consequences
for the resident such as lower quality of life6 and higher psychotropic
drug use7 and higher levels of nursing staff burden.8 Increased burden
in the nursing staff may lead to lower job satisfaction, burn‐out com-
plaints, and absenteeism, further increasing health care costs.4,8-12
Furthermore, caring for someone who shows NPS may be more
time‐consuming, and consequently, there may be less time for other
residents. This may put a strain on quality of care. Although research
onYOD nursing home residents is scarce, research thus far shows that
NPS are present in nearly 90% of residents13,14 and is associated with
lower quality of life of the resident15 and high levels of nursing staff
burden.16 Furthermore, almost 88% of the nursing home residents
with YOD use psychotropic drugs.13
In the Netherlands, nursing home residents with YOD reside on
special care units (SCUs) because they have specific care needs
regarding daytime activities, social contacts, and mobility.17,18 Care is
provided by a multidisciplinary team, consisting of an elderly care phy-
sician,19 health care psychologist, and nursing staff, all with specific
expertise on care and treatment of YOD.
Regarding the management of NPS, there was no specific interven-
tion for YOD nursing home residents available. Therefore, in the
BEYOND‐II study, an intervention was developed aimed at the man-
agement of NPS in YOD nursing home residents.20 This was based
on an intervention that was effective in nursing home residents with
late‐onset dementia.21 The intervention consists of an educationalprogram and a care program that focuses on a multidisciplinary and
systematic management of NPS in YOD. The aim was to reduce NPS
and psychotropic drug use, which may also result in decreased work‐
related burden and absenteeism in nursing staff. It was the first inter-
vention developed specifically for the management of NPS in nursing
home residents with YOD. The use of the intervention was equally
effective as care as usual in terms of the prevalence of neuropsychiat-
ric symptoms and psychotropic drug use as well as nursing staff burn-
out, job satisfaction, and job demands.22,23 Given these findings, the
intervention should be equally or less costly as usual care to warrant
implementation. Therefore, it is important to gain insight in costs of
the intervention to provide information to health care decision makers
for more rational decision making. We performed a cost‐consequence
analysis for estimating the value for money of the intervention, in
which the costs and consequences are presented in a disaggregated
format.24 The aim of this study was to compare the costs and the con-
sequences of the intervention for the management of NPS with nurs-
ing home care as usual.2 | METHODS
2.1 | Design
A cost‐consequence analysis was performed alongside a cluster‐
randomized controlled trial which lasted from September 2015 to
April 2017. The details of this trial are described elsewhere.20 Cluster
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the staff level. A stepped wedge design was used to evaluate the
effect of the care program for the following reasons. It allows all clus-
ters (in this case, groups of YOD special care units) to cross over from
the control to the intervention condition over time, assuring that all
units receive the intervention at the end.25 This increases motivation
for clusters to enroll and stay in the study. Also, training of the clus-
ters' staff could be stepwise by cluster over time instead of providing
training to half of the clusters at once as in two‐arm trial. Furthermore,
several designs were compared in terms of power at the design stage,
and a stepped wedge trial was likely the most powerful for the scenar-
ios envisaged. Thirteen YOD SCUs were randomly divided across
three groups, with two groups of four and one group of five YOD
SCUs. There were four assessments at 6‐month intervals during a
period of 18 months. After the baseline assessment, the first group
started working according to the care program, and from then on after
each assessment, a new group entered the intervention condition.
YOD SCUs in the control condition continued to offer care as usual.
At the last assessment, all SCUs were in the intervention condition.2.2 | Participants
YOD SCUs were recruited through nursing homes affiliated with the
DutchYOD Knowledge Center. People with YOD who had a diagnosis
of dementia with symptom onset before the age of 65 and who had
been residing in the SCU for at least 1monthwere included in the study.
People with dementia caused by human immunodeficiency virus (HIV),
traumatic brain injury, Down syndrome, Korsakov or Huntington dis-
ease were excluded from the study. If a resident moved from the unit
or died, a newly admitted resident was invited to participate in the
study. All nurses employed in theYOD SCU were invited to participate
in the study, irrespective of educational level and hours of employment.2.3 | Intervention
The development of the intervention “Grip on NPS in institutionalized
people with YOD” is described in full detail elsewhere.26 The first 2FIGURE 1 The five steps of the care program “Grip on NPS in institutiomonths of the intervention covered the educational program and a
start‐up phase for learning to work with the care program (Figure 1).
During this period, the elderly care physician completed the first step
of the care program by using a tool for the evaluation of the appropri-
ateness of psychotropic drug prescription for NPS that was derived
from the Appropriateness of Psychotropic Drug Prescription In
Dementia (APID) instrument.27 After this initial evaluation, the
physicians could decide to perform a reevaluation at their own discre-
tion. After the first 2 months, the multidisciplinary team started with
the four circular steps: detection, analysis, treatment, and evaluation.
The detection of symptoms of NPS could take place during nurses'
usual daily observations or every 6 months with a screening tool by
the vocational nurse. After detection of NPS, nurses performed an
analysis of possible causes of NPS and presence of unmet needs by
means of a needs assessment tool that was derived from the Dutch
version of the Camberwell Assessment of Need for the Elderly.28
The analysis was continued by the elderly care physician or psycholo-
gist. The outcome of the analysis and the options for treatment were
discussed in multidisciplinary meetings, and a treatment plan was
established. The treatment plan consisted of a description of the
frequency and severity of the current NPS and the aim in terms of
frequency and severity of the NPS. The intervention did not prescribe
a specific treatment as this is based on the specific causes of NPS. In
line with the guidelines, psychosocial treatments were preferred
above treatment with psychotropic drugs. The treatment was evalu-
ated by comparing the frequency and severity of NPS before and after
treatment. If the results of the evaluation were unsatisfactory, the
analysis could be redone, or another treatment could be considered,
else the detection phase would start again. All steps of the care pro-
gram were supported by digital forms. After 6 months, a follow‐up
training took place.2.4 | Care as usual
Residents not receiving the intervention received care as usual. Care
as usual regarding NPS is less structured compared with the interven-
tion and often consists of the following steps: The nurse consultsnalized people with YOD.”26 Note. Reprinted with permission
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cusses the symptoms in a multidisciplinary meeting. The health care
psychologist and/or elderly care physician perform an analysis
together with the nursing staff and, if necessary, establish a treatment
plan. The treatment is evaluated in multidisciplinary meetings. How-
ever, there are many differences in the extent to which these steps
are performed in nursing homes. For instance, the evaluation of the
treatment of NPS with standardized instruments might not be per-
formed every time.2.5 | Data collection and ethical considerations
The data were collected retrospectively; at each time‐point, the
research assistants contacted the participating YOD SCUs by tele-
phone for collecting data regarding unit size, number of beds, number
of residents, the number of full‐time equivalents on the unit, and staff
absenteeism. The data on staff absence were delivered by the Human
Resources Management department of the nursing home. Psychotro-
pic drug use was derived from the resident's medical file. The data
on time investment of the elderly care physician and health care psy-
chologists were collected on T1 and T3 by means of a diary.2.6 | Ethical considerations
The BEYOND‐II study protocol was approved by the Medical Ethics
Committee region Arnhem/Nijmegen (file number: 2015‐1558). This
research project was conducted according to the principles of the
Declaration of Helsinki (version November 2013, www.wma.net) and
is in agreement with the law regarding medical‐scientific research in
humans. Written informed consent was obtained from the legal repre-
sentative of each resident.2.7 | Cost outcomes
The costs were analyzed from a health care perspective. The costs of
staff absence, psychotropic drug use, and time investment of the
elderly care physician and health care psychologist were included.
Changes in costs were expected to be observable after the SCU had
been exposed to the intervention condition for 6 months. For the cal-
culation of costs, we adhered to the “Manual for Healthcare Costs
Analysis” provided by Zorginstituut Nederland.29
The costs of staff absence were based on the percentage of nurs-
ing staff absence of the total number of full‐time equivalents on the
SCU. The costs of the number of full‐time equivalents were based
on the mean hourly wages per full‐time equivalent of nursing staff
working in nursing homes.
The costs of time investment of elderly care physicians and health
care psychologists on the management of NPS were estimated using
diaries. For 3 weeks, the amount of time in minutes spent on the man-
agement of NPS for each resident was registered. This included
physical/psychological examination, consultation, and treatment. Time
spent on the management of NPS was multiplied with the mean salaryper hour of these professionals and extrapolated to 6 months. The
time invested by the nursing staff was not registered because
throughout their shift, nursing staff continuously spend time on the
prevention and management of NPS making it difficult to separate
time spend on NPS from time spend on other tasks.
The costs of the educational program were calculated as follows:
The educational program and the follow‐up training after 6 months
covered in a total of 5.5 hours, and this was multiplied with the mean
salary costs per discipline per hour and divided by the number of res-
idents on the YOD SCU. The mean salary costs per discipline were
derived from the Dutch collective labor agreement for professionals
working in nursing homes.30
The data about the use of psychotropic drugs were derived from
the nursing home pharmacist's electronic prescription system. Psycho-
tropic drugs prescribed pro re nata were discarded. Per prescription,
the Anatomical Therapeutic Chemical code, dosage, and frequency
(daily, weekly, and monthly) were registered. The dosage was regis-
tered as a total dosage per day, week, or month. The pharmaceutical
price of the psychotropic drugs was retrieved from the website
www.medicijnkosten.nl. Generic product prices were used because
our intervention is not expected to influence the choice of brands.
The costs per prescription were summed into total costs of psychotro-
pic drugs per resident, per half year.
Composite cost measure contained the sum of costs of staff
absenteeism, costs on psychotropic drugs, and costs of the educa-
tional program.3 | STATISTICAL ANALYSIS
All analyses were performed using SPSS version 25. The analyses
included all residents and staff members of whom we had information
for at least one period. All outcomes were checked for missing values,
normality, and outliers. Missing values were present on the outcomes
“costs of staff absenteeism” and “costs of time investment of the
elderly care physician and health care psychologist.” Missing values
on the outcome “costs of staff absenteeism” were considered to be
missing (completely) at random and imputed using the median costs
in both study conditions. Regarding “costs of time investment of the
elderly care physicians and health care psychologist,” more than 50%
of all values were missing (not completely at random), and therefore,
imputation was not sensible to perform. Therefore, only the mean
time and mean costs of the professionals on available data were
described. Costs of psychotropic drug use were analyzed at the resi-
dent level, whereas costs of staff absenteeism and the composite cost
measure were analyzed at the unit level. The effects of the interven-
tion on the costs at unit level were investigated using linear mixed
models with a random effect for YOD SCU to take into account corre-
lation of the repeated measures over time of the costs at unit level. If
costs were measured at resident level, additionally, a random effect of
resident nested within unit was included. With this model, we esti-
mated the main effect of the intervention and the main effect of time
(fixed effect for intervention and fixed effects for three categorical
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the composite cost measure. In all analyses, a P value of <.05 was con-
sidered statistically significant.4 | RESULTS
In total, 274 NH residents with YOD participated in this study divided
over 13 nursing homes throughout the Netherlands. The mean num-
ber of beds on the SCU was 25 (SD: 11). On average, 24 nursing staff
members were working on the SCU, with an average full‐time equiva-
lent of 21.84 (SD: 15.3). At baseline, the costs were on average
€1709.67 and consisted of the costs of psychotropic drug use, which
were on average €35.48 per resident per half year, and costs of staff
absenteeism which were on average €1674.80 per resident per half





Psychotropic drugs 35.48 (56.81) 0‐376.38
Staff absenteeism 1674.80 (183.30) 0‐8937.55
Composite cost measurea 1709.67 (183.49) 0‐9084.61
aAt baseline, the costs of the educational program were €0.
TABLE 2 Costs per resident per half year for the time investment of
elderly care physicians and psychologists regarding the management
of NPS
Care as Usual Intervention
Elderly care physician
n 64 residents 74 residents
Involvement of professional 43.7% 64.9%
Mean time investment 69 (79) minutes 40 (52) minutes
Mean costs (SD) 292.52 (605.40) 255.73 (445.45)
Health care psychologist
n 72 residents 133 residents
Involvement of professional 54.2% 51.1%
Mean time investment 56 (54) minutes 72 (144) minutes
Mean costs (SD) 207.32 (330.90) 253.37 (745.72)
TABLE 3 Effects of the intervention and time‐effects on costs
Intervention T1
Estimate 95% CI Estimate 95% CI
Costs of psychotropic drugs −13.65 −29.92 to 2.61 3.88 −10.5
Costs of staff absence −16.95 −438.51 to 404.61 −29.99 −383.7
Composite cost measure 161.77 −257.70 to 581.24 −36.27 −388.2
Note. All costs are in EUR.
*P < .05.4.1 | Costs of the time investment of the
professionals
The data on the time and costs of time investment regarding the man-
agement of NPS showed that with care as usual, the elderly care phy-
sician was involved in 43.7% of the residents. This increased to 64.9%
of the residents after working with the intervention for 6 months
(Table 2). The mean costs of the time of investment of the elderly care
physician in the care decreased from €292.52 (SD €605.40) at the
time the care program was not yet used to €255.73 (SD €445.45)
when the intervention was in use.
The health care psychologist was involved in 51.1% of the resi-
dents, and this remained more or less equal after working with the
intervention for 6 months (54.2%). The mean costs of the time invest-
ment of the health care psychologist increased from €207.32 (SD
€330.90) to €253.37 (SD €745.72) when using the intervention.4.2 | Results of the intervention on costs
With regard to the effect of the intervention on costs, linear mixed
model analyses showed no statistically significant increase in the com-
posite cost measure. No significant time effects were found for the
composite cost measure. There was no statistically significant effect
of the intervention on the costs of staff absenteeism, also no statisti-
cally significant time effects were found. There was no statistically sig-
nificant effect of the intervention compared with care as usual on the
costs of psychotropic drugs. A statistically significant increase in the
costs of psychotropic drugs were found 1 year after baseline (T2 esti-
mated effect: €19.05, P = .029, 95% CI, 1.96‐36.14). The costs for the
educational program offered to all staff on the SCU were on average
€174.13 (SD € 38.63) per resident (Table 3).5 | DISCUSSION
To the best of our knowledge, this is the first study to evaluate the costs
of an intervention for the management of NPS in YOD nursing home
residents. Although the costs of the time investment of professionals
have to be interpreted with caution, it appeared that due to the inter-
vention, there was a shift in costs. The elderly care physician was more
often consulted in the intervention condition, yet the average time
investment decreased, resulting in lower costs compared with care asT2 T3
Estimate 95% CI Estimate 95% CI
1 to 18.27 19.05* 1.96 to 36.14 15.36 −5.75 to 36.74
5 to 323.77 159.11 −262.96 to 581.19 331.12 −199.29 to 861.53
8 to 315.74 94.34 −325.64 to 514.33 225.83 −301.96 to 753.61
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equally often in both conditions but with the use of the intervention
the time investment and thus costs increased. We found no significant
effect of the intervention compared with care as usual on the costs of
psychotropic drug use, staff absenteeism, and the composite cost mea-
sure. The costs of the educational program offered to all staff members
on the special care unit were on average €174.13 per resident.
Although the change in costs of the time investment of the profes-
sionals have to be interpreted with caution, this may be may be related
to aspects of the care program focusing on the analysis of unmet needs
as a cause of NPS and treatment of NPS with psychosocial interven-
tions, both aspects belong to the profession of the health care psychol-
ogist. The effect of the intervention on the costs of these professionals
is especially interesting because the amount of time available for the
special care unit can be reshifted across the professionals. Furthermore,
the guidelines regarding the treatment ofNPS prefer psychosocial inter-
ventions above treatment with psychotropic drugs. Future studies
should therefore aim to investigate the effectiveness of the interven-
tion regarding the time‐investment of these professionals with mixed
model analysis. Besides that, it should be explored what the effect of
the intervention is in terms of shift between time spend by the health
care psychologist and elderly care physician.
In the grip on challenging behavior study, which focused on late‐
onset dementia, a cost‐effectiveness study was performed making it
difficult to fully compare the results.31 The costs of psychotropic drugs
significantly decreased in their study; in addition, positive significant
effects were found on the use of antipsychotics and antidepres-
sants.21 In our study, a nonsignificant decrease in costs of psychotro-
pic drugs related to the use of the intervention was found while over
time the costs of the psychotropic drugs increased. This latter finding
cannot be related to inflation, as we calculated the costs of all psycho-
tropic drugs afterwards. We have no further explanation for the
increase of psychotropic drug costs over time. The average costs of
the educational program per resident were slightly higher in their
study (€190) than in our study (€174.13).
The main strength of our study is that we included a large group of
nursing home residents with YOD. However, our study also has limita-
tions. First, all participating nursing homes were affiliated with the
Dutch YOD knowledge center, and as such, these nursing homes
may already have more specialized knowledge and working methods
regarding the treatment of NPS in YOD compared with other nursing
homes. Second, there was a high percentage of missing data on the
outcome time investment, making it impossible to perform a mixed
model analysis on this outcome. As a result, we also had to exclude
this outcome from the calculation of the composite cost measure.
Regarding the time investment on the management of NPS, most pro-
fessionals reported that the diary was too time consuming and there
was too little time available next to their normal work. It is possible
that the professionals that did report time investment represent a
select group. Also, we were not able to assess the time investment
of nursing staff on the management of NPS. Furthermore, despite
the use of electronic client files in the nursing homes and the use of
a web‐based care program, it was not possible to automatically recordthe time investment regarding the management of NPS, for instance,
time needed to complete the digital forms. Even though this would
not have given us full overview of the time investment, it would have
given us insight on the time investment regarding (multidisciplinary)
meetings and registration. Lastly, due to the stepped wedge design,
not all special care units used the intervention for an equally long
period of time. This varied between 6 and 18 months. In case of
extreme behavior, it may take longer than 6 months before an effec-
tive treatment has been established and changes in costs are notice-
able. This may have resulted in an underestimation of the effects.
Lastly, the results of this study can only be generalized to countries
in which a physician and psychologist are involved in the nursing home
care for people with dementia.
In conclusion, the intervention resulted in almost the same amount
of cost compared with care as usual. The costs differences between
care as usual and the use of the intervention are mostly related to
the costs of the educational program which could not entirely be
offset by savings in cost of psychotropic drugs and staff absence. Fur-
thermore, as published earlier, we found no effect of the intervention
compared with care as usual on agitation and aggression and other
NPS and psychotropic drug use.22 However, in our view, the interven-
tion is still of interest for nursing homes in need for methodological
and structured approach towards the management of NPS inYOD res-
idents. Managing NPS is complex and although multiple guidelines are
available, adhering to these guidelines is difficult. Besides that, these
guidelines do not specifically address YOD nursing home residents.
The intervention for the management of NPS in YOD nursing home
residents is a practical translation of the guidelines in which the
involvement of the professionals is predefined, and the focus is on
psychosocial treatments instead of treatment with psychotropic drugs.
Therefore, considerations other than costs may determine if nursing
homes want to implement the intervention for the management of
NPS in YOD nursing home residents.
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